Even though we did not have available an internally controlled model for the study of the effects of the mutation in leukemia cells (such as a knock-in mutant in a T-ALL cell line), we decided to observe some specific phenotypic features of patient’s cells bearing the RPL10 Q123R mutation, compared to other patients of the same cohort. This evidence concerns the gene RPL10 and acute lymphoblastic leukemia.